Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LIPOCOMB 10 MG/10 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LIPOCOMB 10 MG/10 MG CAPSULAS DURAS

Approved

STANDARD

LIPOCOMB 10 MG/10 MG CAPSULAS DURAS

Egis Pharmaceuticals Plc.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 20, 2025
Approval ID: 8e08f9a349e5f1e6
Company: Egis Pharmaceuticals Plc.
Type: Standard

Approval Details

Approval Id: 8e08f9a349e5f1e6
Drug Cima Aemps Name: LIPOCOMB 10 MG/10 MG CAPSULAS DURAS
Register Number: 3135414CIP
Holder Company Name: Egis Pharmaceuticals Plc.
Marketing Company Name: Melyfarma S.L.
Authorization Date: 2025-10-20
Dosage Form: CÁPSULA DURA
Dose: 10 mg/10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Egis Pharmaceuticals Plc.

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 20, 2025

Approval ID

8e08f9a349e5f1e6

Type

Standard

Back to CIMA-AEMPS Approvals